» Articles » PMID: 27483451

Prospective Study of Guideline-tailored Therapy with Direct-acting Antivirals for Hepatitis C Virus-associated Mixed Cryoglobulinemia

Abstract

Conclusion: Interferon-free, guideline-tailored therapy with direct-acting antivirals is highly effective and safe for HCV-associated MC patients; the overall 100% rate of clinical response of vasculitis, on an intention-to-treat basis, opens the perspective for curing the large majority of these so far difficult-to-treat patients. (Hepatology 2016;64:1473-1482).

Citing Articles

Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis C.

Morrone A, Fiorilli V, Cinti L, Roberto P, Ferri A, Visentini M Front Immunol. 2024; 15:1411146.

PMID: 39055707 PMC: 11269149. DOI: 10.3389/fimmu.2024.1411146.


Post-Treatment Occurrence of Serum Cryoglobulinemia in Chronic Hepatitis C Patients.

Dashjamts G, Ganzorig A, Tsedendorj Y, Dondov G, Nergui O, Badamjav T Diagnostics (Basel). 2024; 14(11).

PMID: 38893714 PMC: 11171999. DOI: 10.3390/diagnostics14111188.


Ocular manifestations of cryoglobulinemia: a reappraisal.

Dammacco R, Cimino L, De Simone L, Alessio G, Dammacco F Eye (Lond). 2023; 38(3):585-593.

PMID: 37813978 PMC: 10858169. DOI: 10.1038/s41433-023-02738-y.


Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease.

Sharma P, Sawtell R, Wang Q, Sise M Adv Kidney Dis Health. 2023; 30(4):343-355.

PMID: 37657881 PMC: 10479952. DOI: 10.1053/j.akdh.2023.04.003.


Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21 B cells in hepatitis C virus-cured mixed cryoglobulinemia.

Del Padre M, Marrapodi R, Minafo Y, Piano Mortari E, Radicchio G, Bocci C Front Immunol. 2023; 14:1094871.

PMID: 36845129 PMC: 9945227. DOI: 10.3389/fimmu.2023.1094871.